Szyguła-Jurkiewicz B, Nadziakiewicz P, Zakliczynski M, Szczurek W, Chraponski J, Zembala M, Gasior M
3rd Department of Cardiology, SMDZ in Zabrze, Medical University of Silesia, Katowice, Poland.
Clinical Department of Cardiac Anaesthesia and Intensive Care, SMDZ in Zabrze, Medical University of Silesia, Katowice, Poland.
Transplant Proc. 2016 Jun;48(5):1756-60. doi: 10.1016/j.transproceed.2016.01.079.
The evaluation of prognosis and determination of a long-term treatment strategy is an important element of management in patients with heart failure (HF).
The aim of the study was to determine the prognostic value of the Model for End-Stage Liver Disease (MELD) and its modifications, MELD and serum sodium (MELD-Na) and MELD excluding the international normalized ratio (MELD-XI), as well as other independent risk factors for death during a 4-year follow-up. We analyzed retrospectively 143 patients with advanced HF, evaluated for heart transplant between 2009 and 2011. Patients using warfarin were excluded from the study. The long-term follow-up data were obtained during follow-up visits and/or phone contact with the patients or their families.
The age of the patients was 54 (48-59) years and 88.1% of patients were male. Mortality rate during the follow-up period was 49%. The MELD scores (hazard ratio [HR], 1.12; P < .001), as well as serum high-sensitivity C-reactive protein (hs-CRP; HR, 1.01; P < .01) and N-terminal pro-brain natriuretic peptide (NT-proBNP; HR, 1.01; P < .05) levels, were independent risk factors for death. Receiver operator characteristic analysis indicated that a MELD cutoff of 10 (area under the curve [AUC], 0.756; P < .0001], MELD-XI cutoff of 13.0 (AUC, 0.720; P < .0001), MELD-Na cutoff of 13.0 (AUC, 0.813; P < .0001), hs-CRP cutoff of 4.02 (AUC, 0.686; P < .001), and NT-proBNP cutoff of 1055 (AUC, 0.722; P < .001) were the best predictive values as predictors of death.
MELD, MELD-Na, and MELD-XI scores are prognostic factors for death during a 4-year follow-up. A high MELD score is an independent prognostic factor for death. NT-proBNP and hs-CRP serum concentrations are other independent factors influencing death.
心力衰竭(HF)患者的预后评估及长期治疗策略的确定是管理中的重要环节。
本研究旨在确定终末期肝病模型(MELD)及其改良模型,即MELD与血清钠(MELD-Na)以及排除国际标准化比值的MELD(MELD-XI)的预后价值,以及在4年随访期间其他死亡的独立危险因素。我们回顾性分析了2009年至2011年期间接受心脏移植评估的143例晚期HF患者。使用华法林的患者被排除在研究之外。长期随访数据通过随访就诊和/或与患者或其家属的电话联系获得。
患者年龄为54(48-59)岁,88.1%为男性。随访期间死亡率为49%。MELD评分(风险比[HR],1.12;P <.001)以及血清高敏C反应蛋白(hs-CRP;HR,1.01;P <.01)和N末端脑钠肽前体(NT-proBNP;HR,1.01;P <.05)水平是死亡的独立危险因素。受试者工作特征分析表明,MELD临界值为10(曲线下面积[AUC],0.756;P <.0001),MELD-XI临界值为13.0(AUC,0.720;P <.0001),MELD-Na临界值为13.0(AUC,0.813;P <.0001),hs-CRP临界值为4.02(AUC,0.686;P <.001),NT-proBNP临界值为1055(AUC,0.722;P <.001)作为死亡预测指标具有最佳预测价值。
MELD、MELD-Na和MELD-XI评分是4年随访期间死亡的预后因素。高MELD评分是死亡的独立预后因素。NT-proBNP和hs-CRP血清浓度是影响死亡的其他独立因素。